Nutra Pharma Letter to Shareholders

Nutra Pharma Corporation , a biotechnology company that is developing treatments for Multiple Sclerosis , Human Immunodeficiency Virus , Adrenomyeloneuropathy and Pain, announced today that the Company's Chief Executive Officer, Rik J Deitsch, had published a Shareholder Letter on the Company's website.

http://www.businesswire.com/portal/site/topix/index.jsp?ndmViewId=news_view&newsId=20130925005361&newsLang=en&ndmConfigId=1000639&vnsId=41